GeneDx Holdings (WGSWW) Other Non-Current Liabilities (2020 - 2026)

GeneDx Holdings (WGSWW) has 7 years of Other Non-Current Liabilities data on file, last reported at $71000.0 in Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $71000.0, down 98.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $71000.0 (down 98.93% YoY), and the FY2025 annual result was $1.6 million, down 70.27% from the prior year.
• Other Non-Current Liabilities slipped to $71000.0 in Q1 2026 per WGSWW's latest filing, from $1.6 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $24.0 million in Q4 2022 and troughed at $71000.0 in Q1 2026.
• A 5-year average of $9.8 million and a median of $6.6 million in 2025 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2024 and 2026: Other Non-Current Liabilities surged 5654.55% in 2024, then sank 98.93% in 2026.
• A 5-year view of Other Non-Current Liabilities shows it stood at $24.0 million in 2022, then plunged by 38.65% to $14.7 million in 2023, then slumped by 62.54% to $5.5 million in 2024, then tumbled by 70.27% to $1.6 million in 2025, then slumped by 95.67% to $71000.0 in 2026.
• Business Quant data shows WGSWW's Other Non-Current Liabilities at $71000.0 in Q1 2026, $1.6 million in Q4 2025, and $4.3 million in Q3 2025.